WMT

81.68

-1.29%↓

COST

886.66

-0.43%↓

KO

65.55

-1.59%↓

PEP

167.48

-1.37%↓

PM

131.6

+0.96%↑

WMT

81.68

-1.29%↓

COST

886.66

-0.43%↓

KO

65.55

-1.59%↓

PEP

167.48

-1.37%↓

PM

131.6

+0.96%↑

WMT

81.68

-1.29%↓

COST

886.66

-0.43%↓

KO

65.55

-1.59%↓

PEP

167.48

-1.37%↓

PM

131.6

+0.96%↑

WMT

81.68

-1.29%↓

COST

886.66

-0.43%↓

KO

65.55

-1.59%↓

PEP

167.48

-1.37%↓

PM

131.6

+0.96%↑

WMT

81.68

-1.29%↓

COST

886.66

-0.43%↓

KO

65.55

-1.59%↓

PEP

167.48

-1.37%↓

PM

131.6

+0.96%↑

Search

Procter and Gamble Co.

Suletud

Sektor Tarbekaubad (kaitseaktsiad)

167.17 -1.24

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

166.78

Max

169.31

Põhinäitajad

By Trading Economics

Sissetulek

-617M

3.1B

Müük

330M

21B

P/E

Sektori keskmine

26.95

24.992

Aktsiakasum

1.4

Kasumimarginaal

15.28

EBITDA

-686M

4.9B

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+6.15 upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

21. jaan 2025

Järgmine dividendimakse kuupäev

15. nov 2024

Järgmine aktsia dividendi kuupäev (ex-date)

16. jaan 2025

Turustatistika

By TradingEconomics

Turukapital

518M

404B

Eelmine avamishind

168.41

Eelmine sulgemishind

167.17

Uudiste sentiment

By Acuity

15%

85%

51 / 151 Pingereas Consumer defensive

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

Procter and Gamble Co. Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

18. okt 2024, 11:10 UTC

Peamised uudised
Tulu

Procter & Gamble 1Q Profit Top Views Despite Sales Shortfall

21. okt 2024, 09:51 UTC

Peamised uudised

Starboard Targets Another Health Company. Why Kenvue Is in Its Sights. -- Barrons.com

18. okt 2024, 13:48 UTC

Tulu

Procter & Gamble's Earnings Show Its Price Hikes Aren't Working Anymore -- Barrons.com

18. okt 2024, 12:26 UTC

Market Talk
Tulu

Procter & Gamble's Beauty Portfolio Hit By China Slowdown -- Market Talk

18. okt 2024, 11:56 UTC

Tulu

Procter & Gamble Sales Fall Short Despite Higher Prices -- Barrons.com

18. okt 2024, 11:25 UTC

Tulu

Procter & Gamble Earnings Beat. But Sales Fall Short Despite Higher Prices. -- Barrons.com

18. okt 2024, 11:05 UTC

Tulu

Procter & Gamble's Stock Gains As Profit Beat, Steady Outlook Offset A Sales Miss -- MarketWatch

18. okt 2024, 10:55 UTC

Peamised uudised
Tulu

P&G Earnings: Sales Slip but It Holds the Line on Prices -- WSJ

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble Still Sees Paying Around $10B in Dividends in FY25 >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble Still Sees FY25 Adjusted Free Cash Flow Productivity of 90% >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble: FY24 Included Benefits From Minor Brand Divestitures and Favorable Tax Impacts That Are Unlikely to Repeat to Same Extent in FY25 >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble Now Expects Commodity Cost Headwind of About $200M After Tax for FY25, Which Equates to a Headwind of 8c/Shr; Forex Expected to Be Neutral >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble Still Sees Capital Spending to Be in Range of About 4%-5% of Fiscal 2025 Net Sales >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble Still Sees FY25 Adj EPS Growth in Range of 5%-7% Vs. FY24 Adj EPS $6.59 >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble: Our Organic Sales Growth, Earnings and Cash Results in 1Q Keep Us on Track to Deliver Within Our Guidance Ranges on All Key Financial Metrics for the Fiscal Year >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble: 1Q Organic Sales Increase Was Driven by 1% Increase From Higher Pricing and 1% Increase in Organic Volume >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble Backs FY25 Adj EPS $6.91-Adj EPS $7.05 >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble: Total Incremental Restructuring Chgs Incurred Under Program Beginning in Qtr Ended Dec. 31, 2023, Through Qtr Ended Sept. 30, 2024, Were About $1.2 Billion After Tax >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble: Returned Nearly $4.4B of Cash to Shareowners via More Than $2.4B of Dividend Payments and More Than $1.9B of Share Repurchases in 1Q >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble Still Sees FY25 Organic Sales Growth in Range of 3%-5% >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble Still Sees FY25 EPS Growth in Range of 10%-12% Vs. FY24 EPS $6.02 >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble: Expect Combined Headwinds From Foreign Exchange and Divestitures to Negatively Affect FY25 All-In Sales Growth by About One Percentage Point >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble: During 1Q, Completed Limited Market Portfolio Restructuring With Substantial Liquidation of Operations in Argentina >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble: Mix Had Neutral Impact on Sales Growth for 1Q >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble: Recorded Incremental Restructuring Charges of About $800M in 1Q, Consisting Primarily of Non-Cash Chgs of Accumulated Currency Translation Losses Previously Included in Accumulated Other Comprehensive Income/Loss >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble 1Q Adjusted Free Cash Flow Productivity Was 82% >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble 1Q Operating Cash Flow $4.3B >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble 1Q Organic Sales Growth Up 2% >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble Backs FY25All-In Sales Up 2% To Up 4% >PG

18. okt 2024, 10:55 UTC

Tulu

Procter & Gamble 1Q Adj EPS $1.93 >PG

Võrdlus sarnastega

Hinnamuutus

Procter and Gamble Co. Prognoos

Hinnasiht

By TipRanks

6.15% tõus

12 kuu keskmine prognoos

Keskmine 179.72 USD  6.15%

Kõrge 196 USD

Madal 163 USD

Põhineb 21 Wall Streeti analüütiku instrumendi Procter and Gamble Co. 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

21 ratings

12

Osta

9

Hoia

0

Müü

Tehniline skoor

By Trading Central

N/A / 169.54Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

No Evidence

Sentiment

By Acuity

51 / 151 Pingereas Tarbekaubad (kaitseaktsiad)

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Procter and Gamble Co.

The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, baby stores, specialty beauty stores, e-commerce, high-frequency stores, pharmacies, electronics stores and professional channels. It offers products under the brands, such as Head & Shoulders, Herbal Essences, Pantene, Rejoice, Olay, Old Spice, Safeguard, Secret, SK-II, Braun, Gillette, Venus, Crest, Oral-B, Metamucil, Neurobion, Pepto-Bismol, Vicks, Ariel, Downy, Gain, Tide, Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer, Luvs, Pampers, Always, Always Discreet, Tampax, Bounty, Charmin and Puffs.